SE9702191D0 - Coposition and methods for the treatment of inflammatory dideases - Google Patents

Coposition and methods for the treatment of inflammatory dideases

Info

Publication number
SE9702191D0
SE9702191D0 SE9702191A SE9702191A SE9702191D0 SE 9702191 D0 SE9702191 D0 SE 9702191D0 SE 9702191 A SE9702191 A SE 9702191A SE 9702191 A SE9702191 A SE 9702191A SE 9702191 D0 SE9702191 D0 SE 9702191D0
Authority
SE
Sweden
Prior art keywords
treatment
inflammatory
methods
dideases
coposition
Prior art date
Application number
SE9702191A
Other languages
English (en)
Inventor
Sven Pettersson
Hans Wolf-Watz
Original Assignee
Sven Pettersson
Hans Wolf Watz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sven Pettersson, Hans Wolf Watz filed Critical Sven Pettersson
Priority to SE9702191A priority Critical patent/SE9702191D0/sv
Publication of SE9702191D0 publication Critical patent/SE9702191D0/sv
Priority to EP98928776A priority patent/EP0998492A1/en
Priority to PCT/SE1998/001106 priority patent/WO1998056817A1/en
Priority to AU80490/98A priority patent/AU8049098A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9702191A 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases SE9702191D0 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE9702191A SE9702191D0 (sv) 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases
EP98928776A EP0998492A1 (en) 1997-06-09 1998-06-09 Composition and methods for the treatment of inflammatory diseases
PCT/SE1998/001106 WO1998056817A1 (en) 1997-06-09 1998-06-09 Composition and methods for the treatment of inflammatory diseases
AU80490/98A AU8049098A (en) 1997-06-09 1998-06-09 Composition and methods for the treatment of inflammatory diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702191A SE9702191D0 (sv) 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases

Publications (1)

Publication Number Publication Date
SE9702191D0 true SE9702191D0 (sv) 1997-06-09

Family

ID=20407302

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702191A SE9702191D0 (sv) 1997-06-09 1997-06-09 Coposition and methods for the treatment of inflammatory dideases

Country Status (4)

Country Link
EP (1) EP0998492A1 (sv)
AU (1) AU8049098A (sv)
SE (1) SE9702191D0 (sv)
WO (1) WO1998056817A1 (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0112687D0 (en) * 2001-05-24 2001-07-18 Microbiological Res Authority Pharmaceutical use of secreted bacterial effector proteins
WO2004064713A2 (en) * 2003-01-20 2004-08-05 Vib Vzw The use of yop preoteins or rho gtpase inhibitors as caspase-1 inhibitors
EP1871880B8 (en) * 2005-04-11 2012-09-12 Yeda Research And Development Co., Ltd. Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
CA2726193C (en) * 2008-06-03 2018-11-27 University Of Rochester Methods of treating inflammatory intestinal disease and managing symptoms thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI903414A (fi) * 1990-07-06 1992-01-07 Kansanterveyslaitos Produktion av proteiner i grampositiva bakterier.

Also Published As

Publication number Publication date
AU8049098A (en) 1998-12-30
EP0998492A1 (en) 2000-05-10
WO1998056817A1 (en) 1998-12-17

Similar Documents

Publication Publication Date Title
TR200001982T2 (tr) Farmasötik vurulu salınımlı oral dozaj şekli.
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
TR199801315T2 (xx) X sendromunun tedavisi i�in bir ppar-alpha ve ppar-gamma antagonistinin kullan�lmas�.
BR9813284B1 (pt) aminoácidos cìclicos e derivados dos mesmos úteis como agentes farmacêuticos e composição farmacêutica.
EE9700192A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja antatsiidainet või alginaati
ATE185562T1 (de) Taxol derivate, deren herstellung und diese enthaltende pharmazeutischen zusammenstellungen
EE9700194A (et) Peroraalne farmatseutiline annusvorm, mis sisaldab prootonpumba inhibiitorit ja NSAID
CY1108007T1 (el) Φαρμακευτικες συνθεσεις βοτουλινικης τοξινης
DK1095932T3 (da) Phenoxyeddikesyrederivat og pharmaceutiske sammensætninger omfattende den samme
DE69917609D1 (de) Arzneimittel und deren verwendung
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
PT902789E (pt) Derivados de androsteno
TR199801861T2 (xx) Farmas�tik olarak yararl� bile�imler.
HRP20010277B1 (en) Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
ATE398630T1 (de) Zyklische conotoxin-peptide
ES2168457T3 (es) Composiciones farmaceuticas que comprenden una superoxido dismutasa.
DK1210119T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
NO20010089D0 (no) Farmasöytisk levotyroksinpreparat
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
TR199701536T1 (xx) Benzimidazollerin, l�seminin tedavisi i�in bir ila� �retilmesinde kullan�m�.
TR200100637T2 (tr) Yeni doğal ürün türevleri
ITMI962423A0 (it) Composizione farmaceutica orale ad attivita' antipiretica analgesica e infiammatoria
PT1159960E (pt) Composicoes farmaceuticas baseadas em diclofenac
SE9702191D0 (sv) Coposition and methods for the treatment of inflammatory dideases